Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay.

Article Details

Citation
Copy to clipboard

Sandouk P, Chappey O, d'Yvoire MB, Scherrmann JM

Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay.

Ther Drug Monit. 1995 Oct;17(5):544-8.

PubMed ID
8585121 [ View in PubMed
]
Abstract

The myorelaxant thiocolchicoside (TC), an analogue of colchicine (COL), was assayed in plasma and urine by a radioimmunoassay (RIA) using a cross-reacting COL-specific polyclonal antibody. Cross-reactivity was 56% for TC, giving a limit of quantification of 0.5 ng/ml and a linear response from 0.5 to 100 ng/ml. Specificity was checked by cross-reactivity studies with COL analogues and by using liquid chromatography and RIA in tandem on urine samples. Two immunoreactive peaks were detected, but the nonspecific peak represented < 2% of the total urine concentration of TC. Pharmacokinetics of TC following infusion of 4 mg in two subjects revealed a moderate distribution (Vss from 31 to 35 L) and mainly extrarenal elimination (75% of the total body clearance). Terminal half-lives ranged from 2.4 to 2.7 h in plasma and from 3.2 to 3.7 h in urine.

DrugBank Data that Cites this Article

Drugs